Anna R O'Callaghan1, Louise Morgan1, Julie T Daniels1, Mark P Lewis2. 1. Department of Ocular Biology & Therapeutics, UCL Institute of Ophthalmology, University College London, London EC1V 9EL, UK. 2. National Centre for Sport & Exercise Medicine (NCSEM), EPSRC-MRC Centre for Doctoral Training in Regenerative Medicine, School of Sport, Exercise & Health Sciences, Loughborough University, Leicestershire, LE11 3TU, UK.
Abstract
AIM: To investigate human oral mucosal fibroblasts (HOMF) and human limbal fibroblasts (HLF) as alternatives to murine 3T3 feeder fibroblasts currently used to support epithelial cell expansion for the treatment of limbal epithelial stem cell deficiency. METHODS: HLF and HOMF were compared with 3T3s for their ability to support the culture of human limbal epithelial cells and human oral mucosal epithelial cells. RESULTS: HOMF, but not HLF, were equivalent to 3T3s in terms of the number of epithelial population doublings achieved. Human limbal epithelial cells co-cultured with HOMF or 3T3s had similar expression of corneal and putative stem cell markers. CONCLUSION: HOMF are a suitable and safer feeder fibroblast alternative to 3T3s for the production of epithelial cells for clinical use.
AIM: To investigate human oral mucosal fibroblasts (HOMF) and human limbal fibroblasts (HLF) as alternatives to murine 3T3 feeder fibroblasts currently used to support epithelial cell expansion for the treatment of limbal epithelial stem cell deficiency. METHODS: HLF and HOMF were compared with 3T3s for their ability to support the culture of human limbal epithelial cells and human oral mucosal epithelial cells. RESULTS: HOMF, but not HLF, were equivalent to 3T3s in terms of the number of epithelial population doublings achieved. Human limbal epithelial cells co-cultured with HOMF or 3T3s had similar expression of corneal and putative stem cell markers. CONCLUSION: HOMF are a suitable and safer feeder fibroblast alternative to 3T3s for the production of epithelial cells for clinical use.
Authors: Elham Nili; Fiona J Li; Rebecca A Dawson; Cora Lau; Blair McEwan; Nigel L Barnett; Steven Weier; Jennifer Walshe; Neil A Richardson; Damien G Harkin Journal: Cell Transplant Date: 2019-06-17 Impact factor: 4.064